December2 , 2023

Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars


Edobles Launches Revolutionary Mood-Enhancing Edibles

Miami-Based Company, Edobles, Launches Mood-Enhancing Edibles Expertly Crafted With Natural Ingredient Blends to Boost Customers’ Moods One Bite at a Time

Edobles Launches Revolutionary Mood-Enhancing Edibles
Ed?bles Launches Revolutionary Mood-Enhancing Edibles

Miami-based company, Ed?bles, launches mood-enhancing edibles expertly crafted with natural ingredient blends to boost customers' moods one bite at a time.

Edobles (Edobles, LLC), a new player in the infused edibles industry, has opened its doors and launched its line of products designed to enhance mood. With a focus on catering to various moods, Edobles offers a range of options to boost euphoria, increase energy levels, promote calmness and balance, and induce restful sleep.

“We’re a mood-based company first and foremost,” says Miguel Cruz, Creative Director for the brand, “Our goal is to create a product that’s easy to consume, whether at home or on the go, that’s effective at enhancing or creating a desired mood in one bite.”

In a market saturated with infused edibles, Edobles stands out by providing mood-boosting edibles that are backed by scientific research. Each product is carefully formulated with specific ingredients known for their mood-enhancing properties.

Edobles takes pride in the quality and purity of its products. All items undergo rigorous third-party lab testing to ensure accuracy, safety, and purity. These independent lab tests provide unbiased findings, giving consumers peace of mind when incorporating Edobles products into their daily routines.

The launch of Edobles marks the first-ever company focused solely on mood-enhancement solutions. While there are several infused edibles brands on the market, Edobles is the first to specifically cater to different moods. The range of products, including Energy, Euphoria, and Sleep Edibles, as well as Libido Gummies and more, ensures that individuals can find the perfect option to suit their desired mood.

By prioritizing the quality, safety, and effectiveness of their offerings, Edobles aims to empower individuals to take control of their mood and enhance their overall daily routines. With the launch of its innovative products, Edobles is set to revolutionize the way we approach mood enhancement and well-being.

About Edobles

Edobles is an edible supplements company focused on the science of mood enhancement through the power of all-natural ingredient blends. With mood-enhancing products ranging from providing better sleep and more energy to mental focus and bodily relaxation, we’re committed to giving our customers an all-natural way to enhance any mood or feeling in a new and delicious way. To learn more, please visit or contact us at [email protected].

Contact Information:
Carla Centurion
Company Affairs Liaison
[email protected]

Original Source: Edobles Launches Revolutionary Mood-Enhancing Edibles
gossip news
free fashion tv


New biologics outsourcing solution provider leverages proven track record of Tanvex BioPharma USA Inc. to help early-stage companies bring mammalian and microbial derived biologics from concept to commercialization.

Tanvex BioPharma USA Inc., a developer and manufacturer of biopharmaceuticals, has launched Tanvex CDMO to provide comprehensive biologic contract development and manufacturing services, offering its experience and expertise to the biopharmaceutical industry. 

Tanvex CDMO is an end-to-end biologics outsourcing solution provider located in the heart of San Diego's Sorrento Valley biotech hub. Its 100,000-square-foot facilities include a state-of-art R&D center, two (2) mammalian GMP manufacturing suites, one (1) microbial GMP manufacturing suite, QC laboratories and GMP warehouse. Tanvex CDMO uses high-throughput workflows to accelerate process development and formulation development. Its GMP facilities have been inspected by the U.S. Food and Drug Administration (FDA) and is equipped with single-use technology. 

Tanvex CDMO aims to become a strategic partner to help biopharmaceutical companies advance their products from concept to treatments for patients. Its skilled employees have successfully taken multiple biologics from IND to BLA.

“Our launch of Tanvex CDMO is a testament to our unwavering commitment to advancing biologics development and manufacturing,” said Chief Operating Officer John Mosack. “With state-of-the-art facilities and an experienced team in development and manufacturing, Tanvex CDMO embodies the future of biopharmaceuticals, driving innovation to deliver life-changing biologics to patients worldwide.”  

Tanvex CDMO offers the following suite of services: 

  • Cell line development (microbial & mammalian)
  • Microbial and mammalian process development, optimization and scale-up  
  • Analytical development and phase appropriate qualification/validation
  • Potency assay development 
  • Pre-formulation and drug product formulation development 
  • Clinical to commercial scale microbial and mammalian GMP manufacturing 
  • QC release testing and stability 
  • Regulatory support 

With its in-depth knowledge of biologics development, cutting-edge facilities, and commitment to innovation, Tanvex CDMO is ready to serve the global biopharmaceutical communities and help deliver groundbreaking treatments to patients who need them. 

To contact and learn more about Tanvex CDMO, visit and follow Tanvex CDMO on LinkedIn for regular updates.

About Tanvex CDMO 

Tanvex BioPharma USA Inc. (formerly La Jolla Biologics, Inc.) was founded in 2011 with the mission of making biologics more accessible to patients. The company has successfully brought its first product to approval in Canada, and additional BLAs are pending approval by the FDA. Tanvex BioPharma USA Inc. now offers its technical and operational experience in making microbial and mammalian derived biotherapeutics to a greater audience by becoming a Contract Development and Manufacturing Organization - Tanvex CDMO. Tanvex CDMO brings together biologic drug substance and drug product development, GMP manufacturing and regulatory support services to foster a seamless collaboration experience for our clients while maximizing operational efficiency at every step of the drug development process to accelerate our client’s product from concept to treatments for patients.

Contact Information:
Priyanka Tiwari
Sr. Manager - Marketing
[email protected]
Related Images
Image 2
Image 2

Tanvex CDMO Delivering a Shared Vision

Original Source: Tanvex CDMO Launch Empowers Advancements in Novel Biologics and Biosimilars